197 related articles for article (PubMed ID: 35197508)
21. Different patterns of cytokines and chemokines combined with IFN-γ production reflect Mycobacterium tuberculosis infection and disease.
Yu Y; Zhang Y; Hu S; Jin D; Chen X; Jin Q; Liu H
PLoS One; 2012; 7(9):e44944. PubMed ID: 23028695
[TBL] [Abstract][Full Text] [Related]
22. Association between elevated pleural interleukin-33 levels and tuberculous pleurisy.
Lee KS; Kim HR; Kwak S; Choi KH; Cho JH; Lee YJ; Lee MK; Lee JH; Park SD; Park DS
Ann Lab Med; 2013 Jan; 33(1):45-51. PubMed ID: 23301222
[TBL] [Abstract][Full Text] [Related]
23. Pleural fluid analysis of lung cancer vs benign inflammatory disease patients.
Kremer R; Best LA; Savulescu D; Gavish M; Nagler RM
Br J Cancer; 2010 Mar; 102(7):1180-4. PubMed ID: 20216542
[TBL] [Abstract][Full Text] [Related]
24. The value of matrix metalloproteinase-9 and vascular endothelial growth factor receptor 1 pathway in diagnosing indeterminate pleural effusion.
Fiorelli A; Morgillo F; Fasano M; Vicidomini G; Di Crescenzo VG; Di Domenico M; Accardo M; Santini M
Interact Cardiovasc Thorac Surg; 2013 Mar; 16(3):263-9. PubMed ID: 23190621
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic utility of pleural fluid and serum markers in differentiation between malignant and non-malignant pleural effusions.
Korczynski P; Krenke R; Safianowska A; Gorska K; Abou Chaz MB; Maskey-Warzechowska M; Kondracka A; Nasilowski J; Chazan R
Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):128-33. PubMed ID: 20156743
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of tumor markers in lung adenocarcinoma-associated cytologically negative pleural effusions.
Hsieh TC; Huang WW; Lai CL; Tsao SM; Su CC
Cancer Cytopathol; 2013 Sep; 121(9):483-8. PubMed ID: 23408492
[TBL] [Abstract][Full Text] [Related]
27. Serum and pleural fluid N-Terminal-Pro-B-Type natriuretic peptide concentrations in the differential diagnosis of pleural effusions.
Yorgancıoğlu A; Ozgen Alpaydın A; Yaman N; Taneli F; Bayturan O; Sakar Coşkun A; Celik P
Tuberk Toraks; 2011; 59(1):1-7. PubMed ID: 21554224
[TBL] [Abstract][Full Text] [Related]
28. Use of lateral flow assays to determine IP-10 and CCL4 levels in pleural effusions and whole blood for TB diagnosis.
Sutherland JS; Mendy J; Gindeh A; Walzl G; Togun T; Owolabi O; Donkor S; Ota MO; Kon Fat ET; Ottenhoff TH; Geluk A; Corstjens PL
Tuberculosis (Edinb); 2016 Jan; 96():31-6. PubMed ID: 26786652
[TBL] [Abstract][Full Text] [Related]
29. [Contribution of pleural fluid analysis to the diagnosis of pleural effusion].
Ferreiro L; Toubes ME; Valdés L
Med Clin (Barc); 2015 Aug; 145(4):171-7. PubMed ID: 25433793
[TBL] [Abstract][Full Text] [Related]
30. Expression Profiles of Cytokine mRNAs in the Pleural Fluid Reveal Differences Among Tuberculosis, Malignancies, and Pneumonia-Exudative Pleural Effusions.
Espósito DL; Bollela VR; Feitosa AL; da Fonseca BA
Lung; 2015 Dec; 193(6):1001-7. PubMed ID: 26407584
[TBL] [Abstract][Full Text] [Related]
31. Angiopoietin-2 levels are elevated in exudative pleural effusions.
Kalomenidis I; Kollintza A; Sigala I; Papapetropoulos A; Papiris S; Light RW; Roussos C
Chest; 2006 May; 129(5):1259-66. PubMed ID: 16685017
[TBL] [Abstract][Full Text] [Related]
32. Pentraxin-3: A novel biomarker for discriminating parapneumonic from other exudative effusions.
Ozsu S; Abul Y; Mentese A; Bektas H; Uzun A; Ozlu T; Porcel JM
Respirology; 2013 May; 18(4):657-62. PubMed ID: 23286371
[TBL] [Abstract][Full Text] [Related]
33. GC-MS metabolomics identifies novel biomarkers to distinguish tuberculosis pleural effusion from malignant pleural effusion.
Liu Y; Mei B; Chen D; Cai L
J Clin Lab Anal; 2021 Apr; 35(4):e23706. PubMed ID: 33528039
[TBL] [Abstract][Full Text] [Related]
34. Tumor markers in pleural effusion diagnosis.
Tamura S; Nishigaki T; Moriwaki Y; Fujioka H; Nakano T; Fujii J; Yamamoto T; Nabeshima K; Hada T; Higashino K
Cancer; 1988 Jan; 61(2):298-302. PubMed ID: 3275487
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic performance of different pleural fluid biomarkers in tuberculous pleurisy.
Klimiuk J; Krenke R; Safianowska A; Korczynski P; Chazan R
Adv Exp Med Biol; 2015; 852():21-30. PubMed ID: 25523627
[TBL] [Abstract][Full Text] [Related]
36. Predicting malignant and tuberculous pleural effusions through demographics and pleural fluid analysis of patients.
Valdés L; San-José E; Ferreiro L; Golpe A; González-Barcala FJ; Toubes ME; Rodríguez-Álvarez MX; Álvarez-Dobaño JM; Rodríguez-Núñez N; Rábade C; Gude F
Clin Respir J; 2015 Apr; 9(2):203-13. PubMed ID: 25849297
[TBL] [Abstract][Full Text] [Related]
37. The comparison of pleural fluid TNF-α levels in tuberculous and nontuberculous pleural effusion.
Damayanti N; Yudhawati R
Indian J Tuberc; 2020 Jan; 67(1):98-104. PubMed ID: 32192626
[TBL] [Abstract][Full Text] [Related]
38. Ischemia modified albumin in the differential diagnosis of pleural effusions.
Dikensoy O; Celik N; Kul S; Gogebakan B; Bayram H; Light RW
Respir Med; 2011 Nov; 105(11):1712-7. PubMed ID: 21843931
[TBL] [Abstract][Full Text] [Related]
39. T Helper Cell Subsets in the Pleural Fluid of Tuberculous Patients Differentiate Patients With Non-Tuberculous Pleural Effusions.
Roofchayee ND; Adcock IM; Marjani M; Dezfuli NK; Varahram M; Garssen J; Mortaz E
Front Immunol; 2021; 12():780453. PubMed ID: 34925358
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis of tuberculosis in patients with pleural effusion in an area of HIV infection and limited diagnostic facilities.
Richter C; Perenboom R; Swai AB; Kitinya J; Mtoni I; Chande H; Kazema RR; Chuwa LM; Mwakyusa DH; Maselle SY
Trop Geogr Med; 1994; 46(5):293-7. PubMed ID: 7855915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
